Physician profile
Judith E Schipper
NPI 1619066685
$2,444.20
in general payments reported to CMS, 2019-2025
19 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,487 · 2022: $232 · 2023: $363 · 2024: $221 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $430.48 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $413.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $320.01 | 2021-2024 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.95 | 2023-2025 | Lifevest |
| Glaxosmithkline, LLC. | $190.37 | 2021 | |
| Gilead Sciences, INC. | $168.02 | 2021 | |
| Pfizer INC. | $143.89 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $72.15 | 2021-2023 | |
| Amarin Pharma, INC. | $72.11 | 2021 | |
| Lilly USA, LLC | $63.11 | 2021 | |
| Ibsa Pharma INC. | $51.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.12 | 2021 | |
| Novo Nordisk INC | $48.43 | 2021 | |
| Baxter Healthcare | $35.07 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.44 | 2025 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $17.22 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.84 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.34 | 2021 | |
| Optinose US, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Schipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.